[Effects of aprindine in disorders of the auriculoventricular conduction].
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001283:Atrioventricular Node / Q000187:drug effects / Q000503:physiopathology; D004048:Diethylamines; D004562:Electrocardiography; D006325:Heart Atria / Q000503:physiopathology; D006327:Heart Block / Q000503:physiopathology / Q000627:therapeutic use*; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D007192:Indenes / Q000627:therapeutic use*; D007275:Injections, Intravenous; D010138:Pacemaker, Artificial; D013610:Tachycardia / Q000188:drug therapy / Q000503:physiopathology; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy / Q000503:physiopathology
D000814:Aniline Compounds; D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007189:Indans; D007192:Indenes
Effets de l'aprindine dans les troubles de la conduction auriculoventriculaire